New changes in pregnancy and lactation labelling: Review of dermatologic drugs
Background: The U.S. Food and Drug Administration has published new pregnancy and lactation labelling rules that set standards on the presentation of information with regard to drug usage during pregnancy and breastfeeding, as well as the effects on fertility. These guidelines became effective June...
Saved in:
Main Authors: | Yun Pei Koh, MBBS (Author), Elizabeth A. Tian, BSc (Pharmacy) (Author), Hazel H. Oon, MD, MRCP (UK) (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An overview of upcoming changes in pregnancy and lactation labeling information
by: Mosley JF II, et al.
Published: (2015) -
Understanding the new FDA pregnancy and lactation labeling rules
by: Collin M. Blattner, D.O
Published: (2016) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule
by: Michael Abrouk, et al.
Published: (2017) -
What makes a challenging consult: A cross-sectional study of 1053 dermatology patients in Singapore
by: Ellie Choi, MBBS, MRCP, et al.
Published: (2023) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule
by: Michael Abrouk, BS
Published: (2016)